Feature | September 26, 2013

Medicare Expenses for Patients with Heart Attacks Increase Between 1998 and 2008

Medicare Expenses Growth Heart Attack Patients 1998 2008

September 26, 2013— Medicare expenses for patients with acute myocardial infarction (AMI, heart attack) increased substantially between 1998 and 2008, with much of the increase coming in expenses 31 days or more after the patient was hospitalized, according to a study published by JAMA Internal Medicine, a JAMA Network publication.

Researchers examined Medicare expenses for AMI in part because of large budget deficits in the United States and the high cost of caring for Medicare beneficiaries, according to the study background.

Donald S. Likosky, Ph.D., of the University of Michigan, Ann Arbor, and colleagues compared expenditures by analyzing a sample of Medicare beneficiaries hospitalized with AMI in 1998 and 1999 (n=105,074) and in 2008 (n=212,329).

Researchers found a decline in the number of hospitalizations for AMI, but overall expenses per patient increased by 16.5 percent (absolute difference, $6,094). Of the total increase in expenses, 25.6 percent was for care within 30 days of the date of hospitalization and 74.4 percent was for care one month to one year after. Medicare spending per patient increased by $1,560 within the first 30 days after hospitalization and by $4,535 within 31 to 365 days. Expenses for skilled nursing facilities, hospice, home health agencies, durable medical equipment and outpatient care nearly doubled 31 days or more after hospital admission, according to study results. Results also show mortality within one year of an AMI declined from 36 percent in 1998 through 1999 to 31.7 percent in 2008.

The authors suggest that although Medicare’s current bundled payments may limit spending for patients with AMI within 30 days of the episode, they do not contain spending beyond 30 days, which accounted for most of the expenditure growth.

“This growth in the use of health care services 31 to 365 days after an AMI challenges efforts to control costs. A potential approach is to extend bundled or episode-based reimbursements to periods beyond 30 days,” the study concludes.

In an invited commentary, Ashish K. Jha, M.D., M.P.H., of the Harvard School of Public Health, writes: “Likosky and colleagues report on patterns of care and spending for Medicare beneficiaries hospitalized for an acute myocardial infarction (AMI).”

“The study by Likosky et al, as well as other recent evidence, should be a wake-up call for federal policy makers. Most of Medicare’s current efforts to curtail unnecessary spending, including readmissions and bundled payments, are focused on the first 30 days after admission; only a few programs extend the focus to 90 days,” Jha continues.

“The study by Likosky et al is a timely reminder of the importance of research and data for policy making. Refocusing on services following early post-acute services should be straightforward,” Jha concludes.

For more information: www.newswise.com/institutions/newsroom/13


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now